Zusammenfassung
Die totale Beckenexenteration hat sich in den letzten Jahrzehnten zu einem etablierten und sicheren Verfahren zur Resektion lokal fortgeschrittener Beckenmalignome mit 5-Jahres-Überlebensraten von bis zu 66% je nach Tumorentität und mit einer zufriedenstellenden postoperativen Lebensqualität entwickelt. Eine Beckenwandinfiltration oder resektable Fernmetastasen müssen heute keine Kontraindikation für eine Beckenexenteration darstellen; darüber hinaus kann die Beckenexenteration auch zur Palliation indiziert sein. Auch beim Rektumkarzinomrezidiv können gute Ergebnisse erreicht werden. Ein multidisziplinärer Ansatz in Diagnostik und Therapie ist bei diesen Eingriffen von großer Bedeutung, daher sollten sie in dafür spezialisierten Zentren durchgeführt werden.
Abstract
Over the last decades total pelvic exenteration (TPE) has evolved into an established and safe surgical technique for locally advanced pelvic malignancies. Depending on the type of cancer 5 year overall survival rates of up to 66% and a satisfactory postsurgical quality of life have been reported. Currently infiltration of the pelvic side wall and resectable metasases are not necessarily a contraindication to a curative approach; furthermore, TPE can also be useful in palliative surgery. In locally recurrent rectal cancer TPE is the treatment of choice if the tumor is deemed resectable. A multidisciplinary diagnostic and therapeutic approach is of utmost importance, hence patients should be treated in specialized centers.
Literatur
Brunschwig A (1948) Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer 1:177–183
De Chaisemartin C, Penna C, Goere D et al (2009) Presentation and prognosis of local recurrence after total mesorectal excision. Colorectal Dis 11:60–66
Ferenschild FT, Vermaas M, Verhoef C et al (2009) Total pelvic exenteration for primary and recurrent malignancies. World J Surg 33:1502–1508
Forner DM, Meyer A, Lampe B (2010) Preoperative assessment of complete tumour resection by magnetic resonance imaging in patients undergoing pelvic exenteration. Eur J Obstet Gynecol Reprod Biol 148:182–185
Guren MG, Wiig JN, Dueland S et al (2001) Quality of life in patients with urinary diversion after operation for locally advanced rectal cancer. Eur J Surg Oncol 27:645–651
Hockel M (2006) Ultra-radical compartmentalized surgery in gynaecological oncology. Eur J Surg Oncol 32:859–865
Hockel M, Dornhofer N (2006) Pelvic exenteration for gynaecological tumours: achievements and unanswered questions. Lancet Oncol 7:837–847
Husain A, Akhurst T, Larson S et al (2007) A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration. Gynecol Oncol 106:177–180
Jurado M, Alcazar JL, Martinez-Monge R (2010) Resectability rates of previously irradiated recurrent cervical cancer (PIRCC) treated with pelvic exenteration: is still the clinical involvement of the pelvis wall a real contraindication? a twenty-year experience. Gynecol Oncol 116:38–43
Kohler C, Tozzi R, Possover M et al (2002) Explorative laparoscopy prior to exenterative surgery. Gynecol Oncol 86:311–315
Rahbari NN (2010) Surgery for locally recurrent rectal cancer in the era of total mesorectal excision (TME): Is there still a chance for cure? Ann Surg (in press)
Said HK, Bevers M, Butler CE (2007) Reconstruction of the pelvic floor and perineum with human acellular dermal matrix and thigh flaps following pelvic exenteration. Gynecol Oncol 107:578–582
Torricelli P (2007) Rectal cancer staging. Surg Oncol 16(Suppl 1):49–50
Turns D (2001) Psychosocial issues: pelvic exenterative surgery. J Surg Oncol 76:224–236
Ungar L, Palfalvi L (2006) Pelvic exenteration without external urinary or fecal diversion in gynecological cancer patients. Int J Gynecol Cancer 16:364–368
Vermaas M, Ferenschild FT, Verhoef C et al (2007) Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncol 33:452–458
Wright FC, Crooks D, Fitch M et al (2006) Qualitative assessment of patient experiences related to extended pelvic resection for rectal cancer. J Surg Oncol 93:92–99
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Heger, U., Koch, M., Büchler, M. et al. Totale Beckenexenteration. Chirurg 81, 897–901 (2010). https://doi.org/10.1007/s00104-010-1945-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00104-010-1945-z